Autoantibodies from synovial lesions in chronic, antibiotic treatment-resistant lyme arthritis bind cytokeratin-10

Journal of Immunology

Volumn 177, Issue 4, 2006, Pages 2486-2494

  Ghosh, Srimoyee ^a   Seward, Robert ^b   Costello, Catherine E ^b   Stollar, B David ^a   Huber, Brigitte T ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AUTOANTIBODY; CEFTRIAXONE; CYTOKERATIN 10; DOXYCYCLINE; OUTER SURFACE PROTEIN A;

ANTIBIOTIC THERAPY; ARTICLE; AUTOIMMUNE DISEASE; BORRELIA BURGDORFERI; CHRONIC ARTHRITIS; CROSS REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LYME DISEASE; PRIORITY JOURNAL; SPIROCHETE; SYNOVECTOMY;

EID: 33746881444     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.4.2486     Document Type: Article

References (44)

1. Steere, A. C. 1989. Lyme disease. N. Engl. J. Med. 321: 586-584.
2. Young, J. D. 1998. Underreporting of Lyme disease. N. Engl. J. Med. 338: 1629.
3. Steere, A. C., J. Coburn, and L. Glickstein. 2004. The emergence of Lyme disease. J. Clin. Invest. 113: 1093-104.
4. Steere, A. C., D. Gross, A. L. Meyer, and B. T. Huber. 2001. Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis. J. Autoimmun. 16: 263-268.
5. Steere, A. C., and L. Glickstein. 2004. Elucidation of Lyme arthritis. Nat. Rev. Immunol. 4: 143-144.
6. Carlson, D., J. Hernandez, B. J. Bloom, J. Coburn, J. M. Aversa, and A. C. Steere. 1999. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 42: 2705-2709.
7. Gross, D. M., A. C. Steere, and B. T. Huber. 1998. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J. Immunol. 160: 1022-1028.
8. Gross, D. M., T. Forsthuber, M. Tary-Lehmann, C. Etling, K. Ito, Z. A. Nagy, J. A. Field, A. C. Steere, and B. T. Huber. 1998. Identification of LFA-1 as a candidate auloantigen in treatment-resistant Lyme arthritis. Science 281: 703-706.
9. Chen, J., J. A. Field, L. Glickstein, P. J. Molloy, B. T. Hiiber, and A. C. Steere. 1999. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein of Borrelia burgdorferi. Arthritis Rheum. 42: 1813-1822.
10. Meyer, A. L., C. Trollmo, F. Crawford, P. Marrack, A. C. Steere, B. T. Huber, J. Kappler, and D. A. Hafler. 2000. Direct enumeration of Borrelia reactive CD4 T cells ex vivo using MHC class II tetramers. Proc. Natl. Acad. Sci. USA 97: 11433-11438.
11. Akin, E., J. Aversa, and A. C. Steere. 2001. Expression of adhesion molecules in synovia of patients with treatment-resistant Lyme arthritis. Infect. Immun. 69: 1774-1780.
12. Steere, A. C., A. Gibofsky, M. E. Patarroyo, R. J. Winchester, J. A. Hardin, and S. E. Malawista. 1979. Chronic Lyme arthritis: clinical and immunogenetic differentiation from rheumatoid arthritis. Ann. Intern. Med. 90: 896-901.
13. HI associated cross reactive idiotype expression in patients with Lyme arthritis and neuroborreliosis. Ann. Rheum. Dis. 58: 757-761.
14. Hardin, J. A., A. C. Steere, and S. E. Malawista. 1984. The pathogenesis of arthritis in Lyme disease: humoral immune responses and the role of intra-articular immune complexes. Yale J. Biol. Med. 57: 589-593.
15. Hardin, J. A., L. C. Walker, A. C. Steere, T. C. Trumble, K. S. Tung, R. C. Williams, S. Ruddy, and S. E. Malawista. 1979. Circulating immune complexes in Lyme arthritis: detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays. J. Clin. Invest. 63: 468-477.
16. Ghosh, S., A. C. Steere, B. D. Stollar, and B. T. Huber. 2005. In situ diversification of the antibody repertoire in chronic Lyme arthritis synovium. J. Immunol. 174: 2860-2869.
17. Souto-Carneiro, M. M., H. Burkhardt, E. C. Muller, R. Hermann, A. Otto, H. G. Kraetsch, U. Sack, A. Konig, D. Heinegard, H. K. Muller-Hermelink, and V. Krenn. 2001. Human monoclonal rheumatoid synovial B lymphocyte hybridoma with a new disease-related specificity for cartilage oligomeric matrix protein. J. Immunol. 166: 4202-4208.
18. Armengol, M. P., M. Juan, A. Lucas-Martin, M. T. Fernandez-Figueras, D. Jaraquemada, T. Gallart, and R. Pujol-Borrell. 2001. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am. J. Pathol. 159: 861-873.
19. Carley, W. W., A. Szczepanski, and M. E. Gerritsen. 1996. Cytokeratin expression and hyafuronic acid production in cultures of human synovial microvascular endothelial cells: influence of cytokines and growth factors. Microcirculation 3: 359-370.
20. Mattey, D. L., N. Nixon, C. Wynn-Jones, and P. T. Dawes. 1993. Demonstration of cytokeratin in endothelial cells of the synovial microvasculature in situ and in vitro. Br. J. Rheumatol. 32: 676-682.
21. Wang, X., and B. D. Stollar. 2000. Human immunoglobulin variable region gene analysis by single cell RT-PCR. J. Immunol. Methods 244: 217-225.
22. Grimaitre, M., C. Werner-Favre, V. Kindler, and R. H. Zubler. 1997. Human naive B cells cultured with EL-4 T cells mimic a germinal center-related B cell stage before generating plasma cells: concordant changes in Bcl-2 protein and messenger RNA levels. Eur. J. Immunol. 27: 199-205.
23. Wen, L., M. Hanvanich, C. Werner-Favre, N. Brouwers, L. H. Perrin, and R. H. Zubler. 1987. Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and antimalaria responder B cell frequencies. Eur. J. Immunol. 17: 887-892.
24. Polymenis, M., and B. D. Stollar. 1995. Single-chain anti-DNA Fv. Methods Mol. Biol. 51: 265-264.
25. Bonner, R. F., M. Emmert-Buck, K. Cole, T. Pohida, R. Chuaqui, S. Goldstein, and L. A. Liotta. 1997. Laser capture microdissection: molecular analysis of tissue. Science 278: 1481-1483.
26. Kalish, R. A., J. M. Leong, and A. C. Steere. 1993. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61: 2774-2779.
27. Akin, E., G. L. McHugh, R. A. Flavell, E. Fikrig, and A. C. Steere. 1999. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect. Immun. 67: 173-181.
28. Raag, R., and M. Whitlow. 1995. Single-chain Fvs. FASEB J. 9: 73-74.
29. Griffiths, M. M., and E. F. Remmers. 2001. Genetic analysis of collagen-induced arthritis in rats: a polygenic model for rheumatoid arthritis predicts a common framework of cross-species inflammatory/autoimmune disease loci. Immunol. Rev. 184: 172-183.
30. Matsumoto, I., A. Staub, C. Benoist, and D. Mathis. 1999. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286: 1732-1735.
31. Masson-Bessiere, C., M. Sebbag, E. Girbal-Neuhauser, L. Nogueira, C. Vincent, T. Senshu, and G. Serre. 2001. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the α- and β-chains of fibrin. J. Immunol. 166: 4177-4184.
32. Sims, T. N., and M. L. Dustin. 2002. The immunological synapse: integrins take the stage. Immunol. Rev. 186: 100-104.
33. Hintner, H., N. Romani, U. Stanzl, G. Grubauer, P. Fritsch, and T. J. Lawley. 1987. Phagocytosis of keratin filament aggregates following opsonization with IgG-anti-keratin filament autoantibodies. J. Invest. Dermatol. 88: 176-182.
34. Steere, A. C. 2001. Lyme disease. N. Engl. J. Med. 345: 115-114.
35. Wooten, R. M., and J. J. Weis. 2001. Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr. Opin. Microbiol. 4: 274-279.
36. 753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J. Immunol. 175: 2534-2540.
37. Coulombe, P. A., and P. Wong. 2004. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat. Cell Biol. 6: 699-706.
38. Takeda, I., H. Iwadate, K. Sugisaki, T. Kanno, J. Shinzawa, and R. Kasukawa. 2002. Antikeratin antibodies in sera of patients with connective tissue disease and liver disease. Fukushima J. Med. Sci. 48: 85-92.
39. Mattey, D. L., P. T. Dawes, N. B. Nixon, L. Goh, M. J. Banks, and G. D. Kitas. 2004. Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease. Ann. Rheum. Dis. 63: 420-425.
40. Borg, A. A. 1997. Antibodies to cytokeratins in inflammatory arthropathies. Semin. Arthritis Rheum. 27: 186-195.
41. Steere, A. C., P. H. Duray, and E. C. Butcher. 1988. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis: comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum. 31: 487-495.
42. Stosiek, P., M. Kasper, and K. Conrad. 1990. Immunohistochemistry of cytokeratin expression in human blood vessel endothelia with special reference to synovial connective tissue. Acta Histochem. 89: 61-66.
43. Ma, Y., and J. J. Weis. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 61: 3843-3853.
44. Wardemann, H., S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, and M. C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377.